RBC Life Sciences Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2013. The company reported net sales of $6.7 million for the second quarter of 2013, a 2% increase over the second quarter of 2012. For the second quarter of 2013, the company reported a net loss of $147,000, or $0.01 basic and diluted per share, compared to net earnings of $320,000, or $0.01 basic and diluted per share, for the same quarter last year. Operating loss was $0.198 million against profit of $0.525 million a year ago. Loss before income taxes was $0.226 million against earnings of $0.493 million a year ago.

Net sales were $12.4 million for the six months ended June 30, 2013, a 2% decrease over the same period in 2012. For the six months ended June 30, 2013, the Company reported a net loss of $155,000, or $0.01 basic and diluted per share, compared to net earnings of $247,000, or $0.01 basic and diluted per share for the comparable period in 2012. Operating loss was $0.174 million against profit of $0.438 million a year ago. Loss before income taxes was $0.232 million against earnings of $0.373 million a year ago.